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ABSTRACT
CD4+CD25+ regulatory T cells involved in the regulation of self-tolerance and normality of 
homeostasis. CD122 deficient mice are model animals that have an abnormal immune system 
characteristically have a high number of activated T cells and TER-119 cell decreased. Here we showed 
evidence that the transfer of CD4+CD25+ regulatory T cells derived from normal mice to CD122-
defficient neonates prevent the development of activated memory T cells and elicit TER-119 
differentiation. Bone marrow reconstitution derived from CD122-/- mice to normal mice resulting 
tolerance to individual that genetically different. Importantly, CD4+CD25+ regulatory T cells derived 
from normal mice can replace CD4+CD25+ cells derived from CD122-/- mice. The results of this 
experiment suggest that regulatory T cells from normal mice exert a critical role in maintaining 
peripheral tolerance and controlling hematopoietic disorder.
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INTRODUCTION
Study focused on CD4+CD25+ regulatory T 
cells becomes one attention in immunological 
field. This important cells is known as  ‘naturally 
occurring ‘. Many evidences  explain the ability of 
CD4+CD25+ regulator T cells to prevent the 
development of autoreactive cells [1-5]. CD4 is a 
coreceptor molecule on T cells and it also 
expressed in limited population of macrophages. 
CD4 molecule is also known to become MHC 
class II ligand. On the other hand, CD25 
molecule is known as important receptor for IL-
2. CD25 is a receptor sub unit alpha of  IL-2 (IL-
2Rα). IL-2 receptor has three kinds of chains 
namely alpha, beta, and gamma. Attention of 
scientists against IL-2 receptor alpha (IL2-Rα) 
has had a very broad impact on the medical 
fields, including the discovery of new concepts in 
bone marrow transplantation (BMT).
Loss of CD25 expression due to mutation or 
genetic engineering lead to T cells become anerg-
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gic, a condition in which T cells are not able to 
respond anti-CD3 stimulation. The loss expression 
of CD25 (IL-2Rα) on cell surface is known to 
cause autoimmune diseases [6-16]. CD4+CD25+
regulatory T cells serve as important component to 
maintain normal homeostasis.
To determine whether CD4+CD25+ regulatory 
T cells can be used to overcome hematopoietic 
disorder we transfuse CD4+CD25+ regulatory T 
cells to CD122-/- mice. In this study we found 
evidence that CD4+CD25+ regulatory T cells have 
an ability to normalize the number of TER-119 
and B220 cells. CD4+CD25+ regulatory T cells are 
also important for maintaining self tolerance. In 
bone marrow transplantation CD4+CD25+
regulatory T cells have important role to mediate 




In this experiment we used CD122-/- and 
C57BL/6CD45.1/CD45.1  mice as animal models. 
They were maintained in pathogen free facility. 
CD4+CD25+ regulatory T cells were isolated 
from C57BL/6CD45.1/CD45.1 mice, while the hosts 
were CD122-/-CD45.2/CD45.2 mice. In another 
experiment we transferred bone marrow cells 
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derived from CD122-/- mice to 
C57BL/6CD45.1/CD45.1 mice. Shortly, 5 x 106 bone 
marrow cells derived from CD122-/- mice were 
intravenously injected to C57BL/6CD45.1/ CD45.1 mice 
that had been treated with lethal dose radiation 
(850 rad).
Antibodies
FITC-conjugated anti-mouse CD25 (clone 
PC61.5), Phycoerythrin (PE) or allophycocyanin 
(APCn)-conjugated anti-mouse CD4 (clone 
GK1.5), FITC- or biotin-conjugated anti-mouse 
CD45.1 (clone A20), anti-TER-119, anti-CD62L, 
anti-Gr-1 (clone RB6-8C5), Fluorescein isothio-
cyanate (FITC)-conjugated anti-mouse B220, anti-
mouse CD62L, anti-mouse CD44, and biotin-
conjugated anti-mouse CD122 (clone 5H4). When 
we used biotin-conjugated antibodies, we  
visualized the antibodies by streptavidin-PE-Cy5 
(eBioscience, San Diego, CA).
Flow cytometry and cell sorting.
We performed cell sorting  by using FACS 
Vantage cell sorter (BD-Biosciences, San Jose, 
CA) to obtain highly purified CD4+CD25+
regulatory T cells. Analytical flow cytometry was 
performed by using FACS CaliburTM flow 
cytometer (BD-Biosciences, San Jose, CA). 
Adoptive cell transfer.
Mice which are known as CD122-defficient 
(CD122-/-) in this study have C57BL/ 6CD45.2/CD45.2
lineage. CD122-defficient mice (CD122-/-) is also 
often called the IL-2Rβ knockout. Mice with 
genotype CD122-/- obtained by a breading between 
CD122+/- with CD122+/-. The result of this 
breading produces individuals that follows 
Mendellian laws with genotype  of CD122+/+, 
CD122+/-, and CD122-/-. Mice with genotype of 
CD122-/- can be examined by DNA fingerprinting 
(DNA typing). Mice with genotype CD122-/- (2-
day-old) were adoptively  transfused with 2x105
CD4+CD25+ regulatory T cells derived from 
normal mice that has a genotype of 
CD45.1/CD45.1. CD4+CD25+ regulatory T cells 
are sorted out by FACS Vantage sorting machine 
(BD Biosciences). Analysis of cell surface marker 
was done by FACS machine CaliburTM flow
cytometer (BD-Biosciences, San Jose, CA). Results 
of transfusion were observed 12 weeks after 
treatment. To determine the presence of activated 
T cells we observed CD44 and CD62L molecule 
expressions on T cells. Profiles of B cells were 
observed by looking at the expression of B220, 
while the determination of an occurrence anemia 
we measured  hematocrit from peripheral blood 
aspiration. B220 monoclonal antibody was used to 
determine the existence of B cells, whereas TER-
119 was used to examine erythroblast lineage. 
Statistical analysis
One-way ANOVA was used to analyze the 
data. The differences between groups were 
considered significant at P<0.01. All results were 
presented as the mean of ± SD values of 6 mice 
in each group.
RESULTS AND DISCUSSION
It is known that CD4+CD25+ regulatory T 
cells generally have an ability to regulate homeo
stasis in healthy individuals. In this study 
CD4+CD25+ regulatory T cells were tested for 
their ability to suppress uncontrolled expanded 
Gr1 and B cells in CD122 deficient mice (Figure 
1). The results of the analysis indicate that Gr1 
and B cells level could be normalized in CD122 
deficient mice after receiving CD4+CD25+
regulatory T cells (2 x 105) derived from normal 
mice. In general, this study describes the 
important of CD4+CD25+ regulatory T cells to 
normalize hematopoietic cells in CD122 deficient 
mice. Infusion of CD4+CD25+ regulatory T cells 
in CD122 deficient mice in the age of 2-days 
allowed the mice to develop normally. On the 
other hand, CD4+ CD25- transfusion with the 
same number had no effect in improving survival 
of CD122 deficient mice and the mice will die 
after 10-12 weeks. From these results it is clear 
that the population of T cells that have 
properties with regulatory activity existed in 
CD4+CD25+ cell population. One of the causes 
of death in CD122 deficient mice that were not 
manipulated with regulatory T cells is the 
appearance of high number of Gr1 and also the 
decrease of B cells [17-22]. In many reports, 
activated and memory cells were also contribute 
to the worse condition in CD122 deficient mice. 
It was also reported that naive cells in CD122 
deficient mice decrease dramatically. Exami
nation of T cell absolute number in CD122 
deficient mice showed that the mice have higher 
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number of the cells compare to normal mice. In 
this study could not be explained why the 
memory cells and activated cells could 
accumulate in CD122 deficient mice. Logically, if 
the T cells lose expression of CD122 molecule, 
then T cell number will decrease because CD122 
molecule is a component of IL-2 receptor. But, it 
is unexpected T cells in CD122 deficient mice 
accumulated in the peripheral lymphoid organ 
even though the mice did not respond to the 
proliferation factor (IL-2). According to Abbas 
and the other group [23] T cells in CD122 
deficient mice resistant again  apoptosis .
Figure 1. Adoptive transfer of  CD4+CD25+ regulatory T 
cells derived from normal mice to CD122-/-
neonate mice (2-day- old) increase B and Gr-1 
cells. (a) B220 and Gr-1 profiles of normal mice. 
(b) B220 and Gr-1 profiles of CD122 deficient 
mice. (c) After 12 weeks from the transfer of 
CD4+CD25+ regulatory T cells into CD122-
deficient neonates, spleen cells obtained from 
the mice were stained with anti-Gr-1, anti-TER-
119, and anti-CD45.1 antibodies, then analyzed 
by flow cytometry. Percentages of Gr-1+ and 
B220 cells are shown for cells gated to CD45.1-. 
(d) After 12 weeks from the transfer of 
CD4+CD25- cells into CD122-deficient neonates, 
spleen cells obtained from the mice were stained 
with anti-Gr-1, anti-TER-119, and anti-CD45.1 
antibodies, then analyzed by flow cytometry. 
Percentages of Gr-1+ and B220 cells are shown 
for cells gated to CD45.1-.
In this phenomenon  Malek et al. [24-25] 
postulated that such condition  resulting in 
accumulation of memory cells continued 
throughout life span. Although this opinion is 
not irrefutable, but still leaves the question why 
CD122 deficient mice cell culture were not 
survive compare to normal ones. In normal 
individuals the apoptotic program is necessary to 
maintain the biological balance. Resistance to 
apoptosis in CD122 deficient mice lead to 
accumulation of memory type cells, CD44+CD62-. 
In this study, we found that adoptively transferred 
of CD4+CD25+ regula- tory T cells to CD122-/-
neonate mice can prevent the development of 
memory type (Figure 3). Anemia that occurs in 
CD122 deficient mice can be explained by looking 
at the low erythrocyte precursors (TER-119) in the 
bone marrow (data not shown). However, 
hematopoietic disorder can be seen in spleen. 
TER-119 expression in spleen decrease in CD122-
/- mice. This can be overcome by transferring  
CD4+CD25+ regulatory T cells from normal mice 
(Figure 2).
Figure 2. Adoptive transfer of  CD4+CD25+ regulatory T 
cells derived from normal mice to CD122-/-
neonate mice normalized TER-119 cell 
generation. (a) TER-119 profile of normal mice. 
(b) B220 and Gr-1 profiles of CD122 deficient 
mice. (c) After 12 weeks from the transfer of 
CD4+CD25+  regulatory T cells into CD122-
deficient neonates, spleen cells obtained from 
the mice were stained with anti-TER-119 and 
anti-CD45.1 antibodies, then analyzed by flow 
cytometry. Percentages of TER-119 cells are 
shown for cells gated to CD45.1-. (d) After 12 
weeks from the transfer of CD4+CD25- cells into 
CD122-deficient neonates, spleen cells obtained 
from the mice were stained with anti-TER-119 
and anti-CD45.1 antibodies, and analyzed by 
flow cytometry. Percentages of TER-119 cells 
are shown for cells gated to CD45.1-.
B cells (B220) which has the potential to 
generate antibodies also significantly reduced in 
CD122 deficient mice, so that they were more 
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susceptible then normal ones [26-27]. In this 
study we show that transfusion of CD4+CD25+
regulatory T cells could stimulate the development 
of erythrocyte precursors in the bone marrow. 
Therefore, transfusion of CD4+CD25+ regulatory 
T cells will give opportunity to CD122 deficient 
mice to life normally. The examination of 
hematocrit showed that CD122 deficient mice 
increase the cell ratio to serum after receiving 
CD4+CD25+ regulatory T cells derived from 
normal mice. Hematocrit in normal mice reached 
about 55 whereas in CD122 deficient mice 
dropped dramatically up to 30. The low hematocrit 
in CD122 deficient mice is closely related to the 
ability of bone marrow to generate erythrocytes 
precursor. In observations with marker of TER-
119, proved that CD122 deficient mice were not 
able to produce such precursors (Figure 2). 
Figure 3. Adoptive transfer of  CD4+CD25+ regulatory T 
cells derived from normal mice to CD122-/-
neonate mice increase naïve type cells. (a) Profile 
naïve T cell of normal mice. (b) Profile of naïve 
T cells in CD122 deficient mice. (c) After 12 
weeks from the transfer of CD4+CD25+
regulatory T cells into CD122-deficient neonates, 
spleen cells obtained from the mice were stained 
with anti-CD4, anti-CD62L, anti-CD44, and anti-
CD45.1 antibodies, and then analyzed by flow 
cytometry. Percentages of naïve T cells 
(CD62L+CD44-) are shown for cells gated to 
CD45.1-. (d)  After 12 weeks from the transfer 
of CD4+CD25- T cells into CD122-deficient 
neonates, spleen cells obtained from the mice 
were stained with anti-CD4, anti-CD62L, anti-
CD44, and anti-CD45.1 antibodies, and then 
analyzed by flow cytometry. Percentages of naïve 
T cells (CD62L+CD44-) are shown for cells gated 
to CD45.1-. 
The loss of the ability to produce precursors of 
erythrocytes in CD122 deficient mice is 
suspected of granulocytes penetration into bone 
marrow compartment in beside abnormality  of 
CD8 responses [17, 19, 28-29].
Examination of spleen cells in CD122-/- mice 
showed an increase in memory (CD44+CD62L-) 
type compared to normal ones. In neonate 
CD122-/- mice the abnormalities could be 
overcome by adoptive transfer (transfusion) of 
CD4+CD25+ regulatory T cells as much as 2 x 
105. CD4+CD25+ regulatory T cell transfusions 
might increase naïve cells (CD44-CD62L+). 
CD4+CD25- cells as much as 2 x 105 did not have 
a preventive effect and the status of T cells in 
CD122-/- mice remain in an activated state and a 
memory type (Figure 3). CD122-/- mice severely 
anemic due to a combination of autoimmune 
haemolysis and the defect of erythropoiesis. 
Examination of bone marrow showed that the 
erythrocyte precursor cell with the marker of 
TER-199 dramatically decreased in CD122 
deficient mice. 
Figure 4. Bone marrow transplantation derived from 
CD122-/- neonate mice to normal mice resulting 
a tolerance chimeric mice. (a) After 12 weeks 
from the transfer of bone marrow  cells from 
CD122-deficient neonates to normal mice, 
spleen cells obtained from the mice were stained 
with anti-CD4, anti-CD25, and anti-CD45.1 
antibodies, and then analyzed by flow cytometry. 
Percentage of host remaining cells (15%) are 
shown in upper panel. Percentages of 
CD4+CD25+ regulatory T cells are shown for 
cells gated to CD45.1- in panel (b) and gated to 
CD45.1+ in panel (c).
Erythropoiesis that occurs in CD122 deficient 
mice can be normalized by adoptive transfer 
(transfusion) of CD4+CD25+ regulatory T cells in 
neonate mice as much as 2 x 105, whereas 
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transfusion of CD4+CD25- T cells with the same 
number cannot cure erythropoiesis characterized 
low number of cells that express the TER-119 
(Figure 2). Normalization of TER-119 in spleen 
is also in tune match with the changes in the 
peripheral blood. Hematocrit increased in mice 
CD122-/- T cells that acquire transfusion 
CD4+CD25+ as much as 2 x 105, whereas  
transfusion of CD4+CD25- in the same number 
cannot increase the hematocrit. To determine 
whether CD4+CD25+ regulatory T cells can 
develop in CD122 deficient mice we examined 
with a distinctive profile CD45.1. We found that 
transfusions of CD4+CD25+ regulatory T cells 
from normal mice allowed CD4+CD25+
regulatory T cells from CD122 deficient mice can 
develop in early step but immediately replaced by 
CD4+CD25+ regulatory T cells derived from 
normal ones  (data not shown). 
CONCLUSIONS
CD4+CD25+ regulatory T cells could control 
homeostasis normality in which Gr-1 and B220 
were maintained in appropriate numbers. 
CD4+CD25+ regulatory T cells could suppress the 
development of activated memory type and allow 
hemotopoietic cells remain in the status of naïve 
type.  CD4+CD25+ regulatory T cells maintain 
hematocrit by promoting the development of 
TER-119 cells.
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